Lexeo Therapeutics, Inc. (LXEO) Tops Q4 EPS by 59c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q4 EPS of ($0.27), $0.59 better than the analyst estimate of ($0.86).
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)
- Ideal Power (IPWR) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
